Investec Bank Plc has filed a Form 8.5 public dealing disclosure relating to Advanced Medical Solutions Group Plc (AMS.L) under Rule 8.5 of the Takeover Code.
The disclosure was filed on 25th September 2026, covering dealings that were undertaken on 24th September 2026 by Investec as an exempt principal trader.
Investec Bank Plc holds the role of Advisor and Joint Broker to Advanced Medical Solutions Group Plc, establishing its connected status to the offer party named in the disclosure.
The filing was made in Investec’s capacity as an exempt principal trader with recognised intermediary status, dealing in a client-serving capacity as required under the Takeover Code.
On the purchase side, Investec bought 13,660 ordinary shares in Advanced Medical Solutions Group Plc at a price of 282.3 pence per unit.
On the sales side, the bank sold 71,586 ordinary shares at a price of 282.25 pence per unit, representing a notably larger volume than the purchases recorded.
No cash-settled derivative transactions, stock-settled derivative transactions, or options were reported as part of this disclosure filing.
Investec confirmed there are no indemnity or other dealing arrangements that may constitute an inducement to deal or refrain from dealing with any party to the offer.
The bank also confirmed no agreements, arrangements, or understandings exist relating to voting rights or future acquisition or disposal of relevant securities tied to any derivative.
The disclosure contact listed for the filing is Abhishek Gawde, reachable by telephone, with the disclosure submitted in accordance with requirements set out by the Panel on Takeovers and Mergers.
Public disclosures of this nature under Rule 8 of the Takeover Code are required to be made to a Regulatory Information Service to maintain market transparency during offer periods.
The Panel’s Market Surveillance Unit remains available for consultation regarding dealing disclosure requirements under the Code for any parties with questions.
